Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date.

Relevant risk for interaction seen with cardiac implantable electronic devices; no signs of cardiac damage seen during testing.

Study findings provide valuable clinical information for metastatic castration-sensitive prostate cancer (mCSPC) prognosis in routine clinical practice.

Many cancer patients prefer using telemedicine over in-person visits when completing the informed consent process, a study suggests.

(HealthDay News) — Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing benign prostatic hyperplasia (BPH) surgery, according to a ...

Trial findings shows that urodynamics investigations do not lead to symptom improvement in women with refractory overactive bladder or urgency predominant urinary incontinence. The addition of ...

Compared with painless diabetic neuropathy, painful diabetic neuropathy was associated with higher rates of depression and anxiety and lower quality of life. Painful diabetic peripheral neuropathy ...

Switching to tirzepatide linked to additional reduction in HbA1c, weight loss compared with escalating dulaglutide. (HealthDay News) — For patients with inadequately controlled type 2 diabetes ...

(HealthDay News) — The U.S. Senate has confirmed the appointment of Mehmet Oz, M.D., to head the Centers for Medicare & Medicaid Services (CMS), according to a report from The New York Times.

A nephrologist argues that advancing kidney care in the US requires tailored guidelines addressing ethnic diversity & fragmented healthcare.